Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

NCT02396433 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding.

Conditions

Cancer of the Breast

Interventions

DRUG: Carboplatin
DRUG: Eribulin
DRUG: E7449

Sponsor

The University of Texas Health Science Center at San Antonio